WANG Yong-sheng, LIN Si-yuan, ZHANG Guo-chun. Evaluation of Trastuzumab plus Adjuvant Chemotherapy in Operable HER2-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 80-82. DOI: 10.3969/j.issn.1671-5144.2010.02.011
|
Citation:
|
WANG Yong-sheng, LIN Si-yuan, ZHANG Guo-chun. Evaluation of Trastuzumab plus Adjuvant Chemotherapy in Operable HER2-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 80-82. DOI: 10.3969/j.issn.1671-5144.2010.02.011
|
WANG Yong-sheng, LIN Si-yuan, ZHANG Guo-chun. Evaluation of Trastuzumab plus Adjuvant Chemotherapy in Operable HER2-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 80-82. DOI: 10.3969/j.issn.1671-5144.2010.02.011
|
Citation:
|
WANG Yong-sheng, LIN Si-yuan, ZHANG Guo-chun. Evaluation of Trastuzumab plus Adjuvant Chemotherapy in Operable HER2-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 80-82. DOI: 10.3969/j.issn.1671-5144.2010.02.011
|
DownLoad: